Main Article Content

Authors

Objetive:

The Population-based Cancer Registry of Cali aims to report all new cases in permanent residents within the limits of the city of Cali. Time trends of cancer incidence and mortality are described. The registry has been in continuous operation for 50 years.

Methods:

Cancer cases reports are obtained actively by visiting all sources of information: hospitals, pathology departments, hematology laboratories, radiotherapy centers, government offices where death certificates are processed and physician’s offices. It is estimated that the reporting is at least 95% complete.

Results:

Drastic decreases are documented in rates for tumors causally related to infectious agents, especially cancers of the uterine cervix and the stomach. Gradual increases are documented in rates of tumors linked to affluence and the metabolic syndrome, especially cancers of the colon and the female breast. An unexpected increase in the incidence of papillary carcinoma of the thyroid gland in women is reported. Tobacco-related cancers, especially cancer of the lung, showed marked increase in incidence rates around 1970, apparently the beginning of an epidemic similar to the one reported in Western societies. But the increase in incidence stopped around 1980, resulting from a strong anti-smoking campaign launched in Colombia in the 1970s.

Conclusions:

The findings have influenced prevention strategies implemented by public health authorities, specially the establishment of a city-wide program to prevent cervix cancer via widespread use of vaginal cytology and anti-smoking campaigns. Also, new population-based cancer registries have been established in other Colombian cities as well as in Ecuador.

Bravo, L. E., Collazos, T., Collazos, P., García, L. S., & Correa, P. (2012). Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colombia Medica, 43(4), 246–255. https://doi.org/10.25100/cm.v43i4.1266

1. Correa P. Estudio estadistico del cancer en Antioquia. Antioquia Med. 1955; 5: 589-605.

2. Correa P. Statistical Study of cancer in Antioquia. Scweiz Z Path Bakt. 1955; 18: 491-500.

3. Correa P, Llanos G. Cancer incidence in Cali, Colombia. In: Doll R, Payne P, Waterhouse J, editors. Cancer Incidence in five Continents. Geneva: UICC Springer Verlag; 1966. p. 78-83.

4. Gaitan E, Wahner HW, Correa P, Bernal R, Jubiz W, Gaitan JE. Endemic goiter in the Cauca Valley. I. Results and limitations of twelve years of iodine prophylaxis. J Clin Endocrinol Metab. 1968; 28(12) :1730-40.

5. Correa P, Llanos G. Morbidity and mortality from cancer in Cali, Colombia. J Nat Canc Inst. 1966; 36(4): 717.

6. Aristizabal N, Cuello C, Correa P, Collazos T, Haenszel W. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer. 1984; 34(1): 5-9.

7. Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst. 1970; 44(2): 297-306.

8. Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL. Comparability and quality control in cancer registration. IARC Technical report No 19, Lyon, 1994.

9. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M. et al. Cancer Incidence in Five Continents. Vol. IX. IARC Scientific publications No 160, Lyon, 2007.

10. Doll R, Muir C, Waterhouse J. Cancer Incidence in Five Continents. Vol II. New York: Springer-Verlag Berlin – Heidelberg; 1970.

11. Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer Incidence in Five Continents. Vol. V. Lyon: IARC Press; 1987.

12. Parkin D, Muir C, Whelan S, Gao Y, Ferlay J, Powell J. Cancer Incidence in Five Continents. Vol. VI. Lyon: IARC Press; 1992.

13. Parkin D, Whelan S, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol. VII. Lyon: IARC Press; 1997.

14. Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D. Cancer Incidence in Five Continents. Vol. VIII. Lyon: IARC Press; 2002.

15. Waterhouse J, Muir C, Correa P, Powell J. Cancer Incidence in Five Continents. Vol. III.: IARC Press; 1976.

16. Waterhouse J, Muir C, Shanmugaratnam K, Powell J. Cancer Incidence in Five Continents. Vol. IV. Lyon: IARC Press; 1982.

17. Ferlay J. IARCtools. 2 ed. Lyon, : IARC Press; 2000.

18. Murray C, Lopez AD, Mathers CD, Stein C. The Global Burden of Disease 2000 project: aims, methods and data sources. GPE Discussion Paper No 36. Geneva: WHO; 2001.

19. Estimaciones y proyecciones de población periodo 1985-2020 [database on the Internet]. DANE. [cited 2011]. Available from: http://www.dane.gov.co.

20. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skee RG. Eds. Cancer Registration: Principles and Methods. IARC Scientific Publications. Lyon: IARC: IARC Scientific Publication No. 95; 1991. p. 126-58.

21. Surveillance Research Program NCI. SEER*Stat software. 6.3.5 ed. Bethesda, MD: National Cancer Institute; 2007.

22. Cuello C, Correa P, Haenszel W. Trends in cancer incidence in Cali, Colombia. J Natl Cancer Inst. 1983; 70(4): 635-41.

23. Murillo R, Pineros M, Hernandez G. Atlas de mortalidad por cancer en Colombia. Bogota: Instituto. Nacional de Cancerología. 2003.

24. Haenszel W. Cancer mortality among the foreign-born in the United States. J Natl Cancer Inst. 1961; 26: 37-132.

25. Fox JG, Correa P, Taylor NS, Zavala D, Fontham E, Janney F. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol. 1989; 84(7): 775-81.

26. Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol. 2005; 16(3): 489-511.

27. Menezes A, Lopez M, Hallal P, Muiño A, Perez-Padilla R, Jardim J. Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Pub Health. 2009; 9: 151.

28. Peres J. New PSA guidelines discourage overscreening. J Natl Cancer Inst. 2012; 104(1): 8-9.

29. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012; 104(2): 125-32.

Downloads

Download data is not yet available.
<< < 1 2 3 4 
Received 2012-12-29
Accepted 2012-12-29
Published 2012-12-29

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.